Joachim Yahalom

15PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedRadiation therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka, Tatyana Feldman, Kerry J Savage

|Sep 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.

Harper Hubbeling, Doris Leithner, Emily A Silverman

|Aug 21, 2024
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma.

Kathryn R Tringale, Michael Scordo, Joachim Yahalom

|Jun 25, 2024
Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020.

Kathryn R Tringale, Michael Scordo, Joachim Yahalom

|Jun 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas.

Gustav Y Cederquist, Javin Schefflein, Sean M Devlin

Pageof 3

Frequent Collaborators

9 joint publications

Brandon S Imber

6 joint publications

Andrew D Zelenetz

6 joint publications

Gilles Salles

5 joint publications

Maria Lia Palomba